CD274 and neoplasm: In Raninga's research, auranofin combined with immune checkpoint PD-L1 inhibitor achieved excellent anti-tumor efficacy in breast cancer cell lines and in mice, demonstrating the promising prospect of combined immunotherapy based on gold derivatives (Raninga et al., 2020).